Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Oculusgen (Ologen) Glaucoma MMC Control in Estonia

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2011 by Pro Top & Mediking Company Limited.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Pro Top & Mediking Company Limited
ClinicalTrials.gov Identifier:
NCT00524758
First received: September 4, 2007
Last updated: October 24, 2011
Last verified: October 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2011
  Estimated Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)